Mechanism of basal and transforming growth factor beta 1 stimulated H2O2 release by endothelial cells.
Department of Medicine, New England Medical Center, Boston, MA 02111.
I A
IA
Hertig
P M
PM
Hassoun
J J
JJ
Zulueta
V J
VJ
Thannickal
B L
BL
Fanburg
D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology; D000493:Allopurinol / Q000494:pharmacology; D000818:Animals; D001713:Biphenyl Compounds / Q000494:pharmacology; D002417:Cattle; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000378:metabolism*; D006861:Hydrogen Peroxide / Q000378:metabolism*; D007213:Indomethacin / Q000494:pharmacology; D009637:Masoprocol / Q000494:pharmacology; D009247:NADH, NADPH Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism; D019255:NADPH Oxidases; D009861:Onium Compounds / Q000494:pharmacology; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D014968:Xanthine Dehydrogenase / Q000037:antagonists & inhibitors / Q000378:metabolism; D014969:Xanthine Oxidase / Q000037:antagonists & inhibitors / Q000378:metabolism
D001713:Biphenyl Compounds; D009861:Onium Compounds; D016212:Transforming Growth Factor beta; C031291:diphenyliodonium; D015117:5,8,11,14-Eicosatetraynoic Acid; D000493:Allopurinol; D009637:Masoprocol; D006861:Hydrogen Peroxide; D014968:Xanthine Dehydrogenase; D014969:Xanthine Oxidase; D009247:NADH, NADPH Oxidoreductases; D019255:NADPH Oxidases; D007213:Indomethacin